Hara Tasuku, Ohara Tomoya, Taniguchi Masashi, Sakai Toshiaki, Oka Kohei, Iwai Naoto, Tsuji Toshifumi, Okuda Takashi, Komaki Toshiyuki, Sakagami Junichi, Kagawa Keizo
Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Atsunaka-chou 231, Fukuchiyama, Kyoto 620-8505, Japan.
Case Reports Hepatol. 2020 Oct 14;2020:8824974. doi: 10.1155/2020/8824974. eCollection 2020.
A 77-year-old man with chronic hepatitis C (CH-C) infection, who achieved a sustained virological response (SVR) to interferon (IFN) therapy, was followed up regularly. Before IFN therapy, he did not have metabolic diseases, and the histological diagnosis of his chronic hepatitis was stage-3 fibrosis. After achieving SVR, the fibrosis-4 (FIB-4) index level dropped once but gradually increased. 21 years after SVR, hepatocellular carcinoma (HCC) was diagnosed by dynamic computed tomography. The HCC was 12 mm in diameter. The HCC was treated with radiofrequency ablation. CH-C patients with advanced fibrosis require long-term follow-up, even after achieving SVR.
一名77岁的慢性丙型肝炎(CH-C)感染男性,对干扰素(IFN)治疗获得了持续病毒学应答(SVR),并接受了定期随访。在IFN治疗前,他没有代谢性疾病,其慢性肝炎的组织学诊断为3期纤维化。在实现SVR后,纤维化-4(FIB-4)指数水平一度下降,但随后逐渐升高。在SVR 21年后,通过动态计算机断层扫描诊断出肝细胞癌(HCC)。该HCC直径为12毫米。采用射频消融术对该HCC进行了治疗。即使在实现SVR后,晚期纤维化的CH-C患者仍需要长期随访。